Oral Lichenoid lesions induced by programmed cell death protein 1 and cytotoxic T-lymphocyte-associated protein 4 bispecific antibody: a case report
This report marks the first documented instance of an oral adverse effect associated with Cadonilimab use. It underscores that administration of this agent may lead to significant lichenoid lesions and erosions within the oral cavity-an issue warranting increased vigilance from both oncologists and stomatologists.
Authors
- Renchuan Tao (ORCID: https://orcid.org/0000-0001-8551-0031)
- Qiaozhi Jiang (ORCID: https://orcid.org/0000-0001-7908-8583)
- Sheng Wei (ORCID: https://orcid.org/0000-0001-6888-6301)
- Jiaxuan Wu (ORCID: https://orcid.org/0009-0003-7349-1218)
- Xinyu Chen (ORCID: https://orcid.org/0000-0002-7588-220X)
Institutions
- Guangxi University (CN)
- Guangxi Medical University (CN)
- Guangxi Center for Disease Prevention and Control (CN)
Publication Details
- Journal
- BMC Oral Health
- Published
- 2024-10-18
- DOI
- https://doi.org/10.1186/s12903-024-05036-5
- Citations
- 3
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.85
Funders
- National Natural Science Foundation of China